Professor Emory University, Winship Cancer Institute Atlanta, Georgia, United States
Disclosure(s):
Patrick Sullivan, BS, MD: No financial relationships to disclose
Rapid advances in the field of rectal cancer along with changing patient demographics make the management of the mid-rectal tumor challenging. This session will review the results of the OPRA and PROSPECT trials, the treatment of mismatch-repair-deficient cancers, and special considerations for young adults and patients with inflammatory bowel disease.
